Clinical trial
A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade™ 4.0 in Mastectomy
NCT00943605 is registered in ClinicalTrials.gov with Medtronic Surgical Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade™ 4.0 in Mastectomy
- Lead sponsor
- Medtronic Surgical Technologies
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2009
- Completion date
- March 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
mastectomy